Derivatives of way 100635 as potential imaging agents for 5-ht1a receptors: syntheses, radiosyntheses, and in vitro and in vivo evaluation
- 25 November 1998
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 25 (8) , 769-776
- https://doi.org/10.1016/s0969-8051(98)00020-1
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- [3H]WAY–100635 for 5–HT1A receptor autoradiography in human brain: a comparison with [3H]8–OH–DPAT and demonstration of increased binding in the frontal cortex in schizophreniaNeurochemistry International, 1997
- 5-HT1A and 5-HT2A Receptor mRNAs and Binding Site Densities Are Differentially Altered in SchizophreniaNeuropsychopharmacology, 1996
- Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agentsTrends in Pharmacological Sciences, 1993
- Cortical Pyramidal Neurone Loss May Cause Glutamatergic Hypoactivity and Cognitive Impairment in Alzheimer's Disease: Investigative and Therapeutic PerspectivesJournal of Neurochemistry, 1993
- Treatment strategies for Alzheimer's diseaseThe Lancet, 1992
- Concepts for the design of 5‐HT1A serotonin agonists and antagonistsDrug Development Research, 1992
- Physical evidence of the coupling of solubilized 5-HT1A binding sites with G regulatory proteinsBiochemical Pharmacology, 1990
- Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life.Proceedings of the National Academy of Sciences, 1989
- Recommendations for a practical production of [11C]methyl iodideInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1987
- Buspirone: Action on serotonin receptors in calf hippocampusEuropean Journal of Pharmacology, 1983